Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 1008)

Milan 20133

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Studies at this site

• Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012) — Running, not enrolling